Featured Event Apply to the first edition of AseBio-Merck Award "Advanced Therapies Startup Competition" Madrid España Del 12/09/2022 to 05/10/2022 Healthcare Advanced therapies ¡Deadline extended! You can apply until October 5th
VIVEbiotech and Zelluna Partnership to Advance Off-the Shelf TCR-NK Cell Therapy with GMP ... 19/05/2026 Healthcare Innovative drugs Advanced therapies Partnership during the last 8 years leverages VIVEbiotech’s decade of experience manufacturing GMP ex- and in- vivo... Partners - VIVEbiotech
VIVEbiotech Expands Lentiviral Vector Manufacturing Capabilities with EvoLVcell 18/05/2026 Healthcare Innovative drugs Personalized medicine Advanced therapies Transfection-free stable producer cell line (SCL) offers easy scalability, reduction of cost of goods (COGs), improve... Partners - VIVEbiotech
For the first time, four therapeutic genes have been inserted and one ‘unwanted’ gene rem... 12/05/2026 Healthcare Personalized medicine Advanced therapies These results come from a preclinical study conducted by the Cell Engineering team at Integra Therapeutics using the... Partners - Integra Therapeutics S.L.
ICGT 2026 – 3rd Innovation for Cell and Gene Therapies Congress Gentilly France Del 27/05/2026 to 28/05/2026 Healthcare Advanced therapies
AseBio promotes in Brussels the vision of the Spanish biotechnology sector on the Biotech ... 23/03/2026 Healthcare Rare diseases Innovative drugs Advanced therapies EU projects Our Director General, Ion Arocena, participated in the latest meeting of the MEP Interest Group “EU Biotech and Life... AseBio
ORYZON expands patent protection for iadademstat with grant decision in Mexico covering co... 12/03/2026 Healthcare Advanced therapies Industrial biotechnology Key combination for the treatment of Small Cell Lung Cancer. Partners - Oryzon Genomics
ORYZON reports financial results and corporate update for quarter ended December 31st, 202... 02/03/2026 Healthcare Innovative drugs Personalized medicine Advanced therapies Financing Strong cash position at year-end 2025: $33.3 million (€28.4 million). Partners - Oryzon Genomics
Catch up with Condalab: II Digital Cell Biology Conference 03/03/2026 Healthcare Advanced therapies Condalab invites you to the second edition of our Digital Cell Biology Conference, a free online event aimed at... Partners - CONDALAB
ProtoQSAR and the Institute of Medicinal Chemistry (IQM-CSIC) sign a collaboration agreeme... 23/02/2026 Healthcare Advanced therapies The collaboration combines IQM-CSIC’s expertise in compound design, synthesis, and biological evaluation with ProtoQSAR... Partners - ProtoQSAR
